165 related articles for article (PubMed ID: 29375676)
1. Fibroblast growth factor 21 inhibition aggravates cardiac dysfunction in diabetic cardiomyopathy by improving lipid accumulation.
Chen C; Meng Z; Zheng Y; Hu B; Shen E
Exp Ther Med; 2018 Jan; 15(1):75-84. PubMed ID: 29375676
[TBL] [Abstract][Full Text] [Related]
2. FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation.
Yan X; Chen J; Zhang C; Zhou S; Zhang Z; Chen J; Feng W; Li X; Tan Y
J Cell Mol Med; 2015 Jul; 19(7):1557-68. PubMed ID: 25823710
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-assisted C
Gao J; Liu J; Meng Z; Li Y; Hong Y; Wang L; He L; Hu B; Zheng Y; Li T; Cui D; Shen E
Acta Biomater; 2021 Aug; 130():395-408. PubMed ID: 34129954
[TBL] [Abstract][Full Text] [Related]
5. FGF21-Sirtuin 3 Axis Confers the Protective Effects of Exercise Against Diabetic Cardiomyopathy by Governing Mitochondrial Integrity.
Jin L; Geng L; Ying L; Shu L; Ye K; Yang R; Liu Y; Wang Y; Cai Y; Jiang X; Wang Q; Yan X; Liao B; Liu J; Duan F; Sweeney G; Woo CWH; Wang Y; Xia Z; Lian Q; Xu A
Circulation; 2022 Nov; 146(20):1537-1557. PubMed ID: 36134579
[TBL] [Abstract][Full Text] [Related]
6. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 21 deletion aggravates diabetes-induced pathogenic changes in the aorta in type 1 diabetic mice.
Yan X; Chen J; Zhang C; Zeng J; Zhou S; Zhang Z; Lu X; Chen J; Feng W; Li X; Tan Y
Cardiovasc Diabetol; 2015 Jun; 14(1):77. PubMed ID: 27391008
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator-activated receptor γ coactivator-1α-deficient mice.
Fletcher JA; Linden MA; Sheldon RD; Meers GM; Morris EM; Butterfield A; Perfield JW; Rector RS; Thyfault JP
Exp Physiol; 2018 Mar; 103(3):408-418. PubMed ID: 29215172
[TBL] [Abstract][Full Text] [Related]
9. Systemic Delivery of siRNA Specific for Silencing TLR4 Gene Expression Reduces Diabetic Cardiomyopathy in a Mouse Model of Streptozotocin-Induced Type 1 Diabetes.
Zhang Y; Li Y; Huang X; Zhang F; Tang L; Xu S; Liu Y; Tong N; Min W
Diabetes Ther; 2020 May; 11(5):1161-1173. PubMed ID: 32285313
[TBL] [Abstract][Full Text] [Related]
10. The protective effect of FGF21 on diabetes-induced male germ cell apoptosis is associated with up-regulated testicular AKT and AMPK/Sirt1/PGC-1α signaling.
Jiang X; Chen J; Zhang C; Zhang Z; Tan Y; Feng W; Skibba M; Xin Y; Cai L
Endocrinology; 2015 Mar; 156(3):1156-70. PubMed ID: 25560828
[TBL] [Abstract][Full Text] [Related]
11. Neohesperidin Exerts Lipid-Regulating Effects in vitro and in vivo via Fibroblast Growth Factor 21 and AMP-Activated Protein Kinase/Sirtuin Type 1/Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1α Signaling Axis.
Wu H; Liu Y; Chen X; Zhu D; Ma J; Yan Y; Si M; Li X; Sun C; Yang B; He Q; Chen K
Pharmacology; 2017; 100(3-4):115-126. PubMed ID: 28554169
[TBL] [Abstract][Full Text] [Related]
12. Exercise Prevents Cardiac Injury and Improves Mitochondrial Biogenesis in Advanced Diabetic Cardiomyopathy with PGC-1α and Akt Activation.
Wang H; Bei Y; Lu Y; Sun W; Liu Q; Wang Y; Cao Y; Chen P; Xiao J; Kong X
Cell Physiol Biochem; 2015; 35(6):2159-68. PubMed ID: 25896313
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice.
Ye D; Wang Y; Li H; Jia W; Man K; Lo CM; Wang Y; Lam KS; Xu A
Hepatology; 2014 Sep; 60(3):977-89. PubMed ID: 24590984
[TBL] [Abstract][Full Text] [Related]
14. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
[TBL] [Abstract][Full Text] [Related]
15. Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy.
Pang A; Hu Y; Zhou P; Long G; Tian X; Men L; Shen Y; Liu Y; Cui Y
Cardiovasc Diabetol; 2015 Oct; 14():134. PubMed ID: 26446774
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway.
Zhang C; Huang Z; Gu J; Yan X; Lu X; Zhou S; Wang S; Shao M; Zhang F; Cheng P; Feng W; Tan Y; Li X
Diabetologia; 2015 Aug; 58(8):1937-48. PubMed ID: 26040473
[TBL] [Abstract][Full Text] [Related]
17. The protective effect of fibroblast growth factor-21 in alcoholic cardiomyopathy: a role in protecting cardiac mitochondrial function.
Ferrer-Curriu G; Guitart-Mampel M; Rupérez C; Zamora M; Crispi F; Villarroya F; Fernández-Solà J; Garrabou G; Planavila A
J Pathol; 2021 Feb; 253(2):198-208. PubMed ID: 33125701
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats.
Tanajak P; Sa-Nguanmoo P; Wang X; Liang G; Li X; Jiang C; Chattipakorn SC; Chattipakorn N
Acta Physiol (Oxf); 2016 Aug; 217(4):287-99. PubMed ID: 27119620
[TBL] [Abstract][Full Text] [Related]
19. Combination Therapy of Alpha-Lipoic Acid, Gliclazide and Ramipril Protects Against Development of Diabetic Cardiomyopathy
Dugbartey GJ; Wonje QL; Alornyo KK; Robertson L; Adams I; Boima V; Mensah SD
Front Pharmacol; 2022; 13():850542. PubMed ID: 35401218
[No Abstract] [Full Text] [Related]
20. Transforming growth factor beta (TGF-β) mediates cardiac fibrosis and induces diabetic cardiomyopathy.
Yue Y; Meng K; Pu Y; Zhang X
Diabetes Res Clin Pract; 2017 Nov; 133():124-130. PubMed ID: 28934669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
